IRIS - Res&Arch Institutional Research Information System - Research & Archive

CARINO, ADRIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.573
EU - Europa 832
AS - Asia 567
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.976
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.566
IE - Irlanda 276
IT - Italia 235
SG - Singapore 195
VN - Vietnam 133
HK - Hong Kong 102
CN - Cina 100
RU - Federazione Russa 54
SE - Svezia 51
FR - Francia 41
FI - Finlandia 37
DE - Germania 30
UA - Ucraina 28
NL - Olanda 17
GB - Regno Unito 12
BE - Belgio 10
KR - Corea 10
AT - Austria 9
TR - Turchia 9
CH - Svizzera 8
PL - Polonia 8
LB - Libano 7
CA - Canada 5
CZ - Repubblica Ceca 4
UZ - Uzbekistan 4
GR - Grecia 3
TW - Taiwan 3
AL - Albania 2
MX - Messico 2
RO - Romania 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
EU - Europa 1
IN - India 1
JP - Giappone 1
LT - Lituania 1
MA - Marocco 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.976
Salva come PNG Salva come JPEG
Città #
Chandler 372
Dublin 276
San Mateo 171
Singapore 149
Dong Ket 133
Hong Kong 102
Perugia 87
Ann Arbor 84
Santa Clara 79
Boardman 76
Medford 71
Princeton 70
Altamura 69
Lawrence 62
Wilmington 58
Andover 46
Beijing 35
Saint Petersburg 21
Redmond 17
Los Angeles 16
Falls Church 13
Des Moines 12
Redwood City 12
Dallas 11
Den Haag 11
Brussels 10
Helsinki 10
Houston 10
Norwalk 10
Seoul 10
Izmir 9
San Paolo di Civitate 8
Ashburn 7
Chicago 7
Vienna 6
Dearborn 5
Rome 5
Woodbridge 5
Jacksonville 4
Munich 4
Cambridge 3
Florence 3
Frankfurt am Main 3
Giugliano In Campania 3
Guangzhou 3
Olomouc 3
Prata Di Pordenone 3
San Diego 3
Toronto 3
Bologna 2
Chiyayi County 2
Hefei 2
Lappeenranta 2
Lausanne 2
London 2
Nanjing 2
Nanning 2
Naples 2
Ottawa 2
Shanghai 2
Shenyang 2
Stenico 2
Stroncone 2
Timisoara 2
Vico Equense 2
Abidjan 1
Alba 1
Amsterdam 1
Athens 1
Avignon 1
Baku 1
Baotou 1
Bastia umbra 1
Beirut 1
Bisaccia 1
Bratislava 1
Brno 1
Caserta 1
Castiglione del Lago 1
Cava Dei Tirreni 1
Cormeilles-en-Parisis 1
Delhi 1
Deruta 1
Esslingen am Neckar 1
Handan 1
Hangzhou 1
Harbin 1
Iglesias 1
Jinan 1
Kiev 1
Kunming 1
Lexington 1
Magdeburg 1
Manila 1
Marseille 1
Milan 1
Moscow 1
Nanchang 1
Napoli 1
New Lenox 1
Totale 2.257
Salva come PNG Salva come JPEG
Nome #
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 88
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 85
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 84
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 76
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 76
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 71
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 66
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 66
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 64
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 62
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 62
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 57
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 57
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 56
DISCOVERY OF BAR704, A POTENT AND SELECTIVE FXR AGONIST, THAT PROTECTS AGAINST LIVER FIBROSIS 56
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities 55
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 54
Su1053 - Bar704, a Potent and Selective Fxr Agonist Protects Against Intestinal Fibrosis 54
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 53
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 53
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 52
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 49
Disruption of TFG beta-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand 49
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 48
Structural insights into Estrogen Related Receptor-β modulation: 4-methylenesterols from Theonella swinhoei sponge as the first example of marine natural antagonists. 48
Tu1738 - The Aryl Hydrocarbon Receptor Mediates Anti-Inflammatory Activities of Natural and Synthetic Pelargonidines in Mouse Models of Colitis 48
Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties 47
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 47
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 47
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 47
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 46
Bile Acids Activated Receptors in Inflammatory Bowel Disease 46
Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR Antagonists 45
Bile acids and their receptors in metabolic disorders 45
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 44
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 44
Cystathionine gamma-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 43
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 43
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 42
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 41
Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1 41
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 39
Bile Acid Signaling in Inflammatory Bowel Diseases 39
Tu1748 - Probiotics Beyond Taxonomy: Evidence that Anti-inflammatory Properties of Live Biotherapeutic Products Require Phenotypic Characterization 38
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 38
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 36
GPBAR1 (TGR5) AGONISM REVERSES ENDOTHELIAL DYSFUNCTION AND LIVER INJURY IN A DIETETIC MODEL OF STEATOHEPATITIS 36
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury 36
Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1 36
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 35
HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes 34
Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis 34
Epoxide functionalization on cholane side chains in the identification of G-protein coupled bile acid receptor (GPBAR1) selective agonists 34
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 33
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 32
Introduction of Nonacidic Side Chains on 6-Ethylcholane Scaffolds in the Identification of Potent Bile Acid Receptor Agonists with Improved Pharmacokinetic Properties 32
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 30
Navigation in bile acid chemical space: Discovery of novel FXR and GPBAR1 ligands 30
Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite 30
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 30
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity 29
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases 26
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 25
Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists 24
Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics 24
Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists 23
New brominated flame retardants and their metabolites as activators of the pregnane X receptor 23
Phallusiasterol C, A New Disulfated Steroid from the Mediterranean Tunicate Phallusia fumigata 21
Investigation on bile acid receptor regulators. Discovery of cholanoic acid derivatives with dual G-protein coupled bile acid receptor 1 (GPBAR1) antagonistic and farnesoid X receptor (FXR) modulatory activity 20
The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIV 18
Inverse Virtual Screening for the rapid re-evaluation of the presumed biological safe profile of natural products. The case of steviol from Stevia rebaudiana glycosides on farnesoid X receptor (FXR) 12
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches 5
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissue 2
Totale 3.161
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.207
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020126 0 0 0 0 0 9 40 9 10 41 13 4
2020/2021394 9 10 7 11 129 24 11 3 18 15 10 147
2021/2022613 8 130 2 27 19 10 19 171 12 39 86 90
2022/20231.081 76 233 10 94 95 94 2 56 366 3 40 12
2023/2024365 19 43 13 10 6 3 91 16 7 19 86 52
2024/2025356 14 87 35 43 110 67 0 0 0 0 0 0
Totale 3.161